Across TCGA pan-cancer cohorts, NOX1 mass-spec protein differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of NOX1’s most consistent transcriptional readouts.
The strongest signal is observed in colon adenocarcinoma (COAD), where NOX1 mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types NOX1 is over-expressed in tumor.
COAD are the cancer types where NOX1 tumor–normal differential expression is most reproducible.